BindingDB logo
myBDB logout

35 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
27789141 58 II. Discovery of a novel series of CXCR3 antagonists with a beta amino acid core.EBI Sanofi Co. Ltd
27789137 63 I. Discovery of a novel series of CXCR3 antagonists. Multiparametric optimization of N,N-disubstituted benzylamines.EBI Sanofi Co. Ltd
27692854 100 N-Arylsulfonyl-a-amino carboxamides are potent and selective inhibitors of the chemokine receptor CCR10 that show efficacy in the murine DNFB model of contact hypersensitivity.EBI Boehringer Ingelheim Pharmaceuticals
26862767 40 Discovery and Characterization of Biased Allosteric Agonists of the Chemokine Receptor CXCR3.EBI Friedrich Alexander University
24486132 38 IV. Discovery of CXCR3 antagonists substituted with heterocycles as amide surrogates: improved PK, hERG and metabolic profiles.EBI Merck Research Laboratories
19299127 55 Exploring a pocket for polycycloaliphatic groups in the CXCR3 receptor with the aid of a modular synthetic strategy.EBI VU University Amsterdam
21570852 84 CXCR3 antagonists: quaternary ammonium salts equipped with biphenyl- and polycycloaliphatic-anchors.EBI VU University Amsterdam
23150943 43 Chemical subtleties in small-molecule modulation of peptide receptor function: the case of CXCR3 biaryl-type ligands.EBI VU University Amsterdam
22931505 69 Chemokine receptor antagonists.EBI National Heart and Lung Institute
18337097 64 Lead identification of 2-iminobenzimidazole antagonists of the chemokine receptor CXCR3.EBI Abbott Bioresearch Center
18068363 19 Development of CXCR3 antagonists. Part 4: discovery of 2-amino-(4-tropinyl)quinolines.EBI UCB Inflammation Discovery
18242988 37 Discovery of small molecule benzimidazole antagonists of the chemokine receptor CXCR3.EBI Abbott Bioresearch Center
18063364 68 Design and optimization of imidazole derivatives as potent CXCR3 antagonists.EBI Amgen Inc.
17448658 53 Discovery and optimization of a series of quinazolinone-derived antagonists of CXCR3.EBI Amgen Inc.
22130135 55 Discovery of potent and specific CXCR3 antagonists.EBI Amgen Inc.
22018463 40 III. Identification of novel CXCR3 chemokine receptor antagonists with a pyrazinyl-piperazinyl-piperidine scaffold.EBI Merck Research Laboratories
21764306 149 Special ergolines efficiently inhibit the chemokine receptor CXCR3 in blood.EBI Novartis Institutes for BioMedical Research
21277198 71 II. SAR studies of pyridyl-piperazinyl-piperidine derivatives as CXCR3 chemokine antagonists.EBI Ligand Pharmaceuticals
20483605 47 Discovery of a novel series of CXCR3 antagonists.EBI Merck Serono SA
19632842 65 Optimization of a series of quinazolinone-derived antagonists of CXCR3.EBI Amgen Inc.
20004096 49 Identification of a new class of small molecule C5a receptor antagonists.EBI Wyeth Research
19647429 35 Novel CXCR3 antagonists with a piperazinyl-piperidine core.EBI Ligand Pharmaceuticals
19631529 74 Imidazo-pyrazine derivatives as potent CXCR3 antagonists.EBI Amgen Inc.
19783143 65 Special ergolines are highly selective, potent antagonists of the chemokine receptor CXCR3: discovery, characterization and preliminary SAR of a promising lead.EBI Novartis Institutes for BioMedical Research
18922694 84 Synthesis and structure-activity relationship of benzetimide derivatives as human CXCR3 antagonists.EBI Johnson& Johnson PRD
19014886 83 Camphor sulfonamide derivatives as novel, potent and selective CXCR3 antagonists.EBI GlaxoSmithKline
18061451 35 Optimization of the heterocyclic core of the quinazolinone-derived CXCR3 antagonists.EBI Amgen Inc.
18032038 38 Development of CXCR3 antagonists. Part 3: Tropenyl and homotropenyl-piperidine urea derivatives.EBI UCB Inflammation Discovery
17964154 27 Development of CXCR3 antagonists. Part 2: Identification of 2-amino(4-piperidinyl)azoles as potent CXCR3 antagonists.EBI UCB Inflammation Discovery
17097877 40 Identification and structure-activity relationships of 1-aryl-3-piperidin-4-yl-urea derivatives as CXCR3 receptor antagonists.EBI UCB
16213722 36 Identification and initial evaluation of 4-N-aryl-[1,4]diazepane ureas as potent CXCR3 antagonists.EBI Pharmacopeia Drug Discovery, Inc.
15911279 9 Synthesis and structure-activity relationship of 3-phenyl-3H-quinazolin-4-one derivatives as CXCR3 chemokine receptor antagonists.EBI Vrije Universiteit Amsterdam